|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,105.00 GBX | -7.97% |
|
-10.44% | -5.58% |
| 04:15pm | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday as Chip Stocks Rebound Despite US-Iran Tensions | MT |
| 04:04pm | ASTRAZENECA : Bernstein remains its Buy rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 295B | |||||
| 1,084B | |||||
| 634B | |||||
| 447B | |||||
| 330B | |||||
| 285B |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
